PPAR activators inhibit endothelial cell migration by targeting Akt

Biochemical and Biophysical Research Communications

Volumn 293, Issue 5, 2002, Pages 1431-1437

  Goetze, Stephan ^a   Eilers, Friedrich ^a   Bungenstock, Anne ^a   Kintscher, Ulrich ^a   Stawowy, Philipp ^a   Blaschke, Florian ^a   Graf, Kristof ^a   Law, Ronald E ^b   Fleck, Eckart ^a   Gräfe, Michael ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Akt; Endothelial cells; ERK MAPK; Migration; PPARs

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CIGLITAZONE; FENOFIBRATE; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PIRINIXIC ACID; PROTEIN KINASE B; TROGLITAZONE; VASCULOTROPIN; WORTMANNIN;

ARTICLE; CELL FUNCTION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; METABOLIC DISORDER; PATHOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULARIZATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTILIPEMIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL MOVEMENT; CELLS, CULTURED; CHROMANS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; HYPOGLYCEMIC AGENTS; IN SITU NICK-END LABELING; LIPID METABOLISM; LYMPHOKINES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PEROXISOME PROLIFERATORS; PHOSPHORYLATION; PROCETOFEN; PYRIMIDINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; THIAZOLES; THIAZOLIDINEDIONES; TIME FACTORS; TRANSCRIPTION FACTORS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VASODILATOR AGENTS;

EID: 18444371741     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00385-6     Document Type: Article

References (29)

1. Peroxisome proliferator-activated receptors in the cardiovascular system
2. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis
3. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor
4. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
5. Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice Arte-rioscler
6. Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: Ending the heartache
7. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol
8. Atherosclerosis
9. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipo-protein E-deficient mice
10. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization
11. Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo
12. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration
13. Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway
14. Akt takes center stage in angiogenesis signaling
15. Expression and function of PPARgamma in rat and human vascular smooth muscle cells
16. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells
17. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells
18. Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes
19. Induction of human vascular endothelial stress fibres by fluid shear stress
20. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt
21. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12 14-prostaglandin J2
22. PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells
23. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators
24. Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for effcient chemotaxis to cAMP in Dictyostelium
25. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
26. Regulation of cell contraction and membrane ruffing by distinct signals in migratory cells
27. Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix
28. PPARgamma-ligands inhibit nuclear but not cytosolic ERK-MAPK-regulated steps in vascular smooth muscle cell migration
29. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells